Literature DB >> 17667509

The impact of margins on outcome after hepatic resection for colorectal metastasis.

Chandrakanth Are1, Mithat Gonen, Kathleen Zazzali, Ronald P Dematteo, William R Jarnagin, Yuman Fong, Leslie H Blumgart, Michael D'Angelica.   

Abstract

OBJECTIVE: To analyze the impact of margin width on long-term outcome after hepatic resection for colorectal metastasis. SUMMARY BACKGROUND DATA: The optimal margin width and its influence on long-term outcome after hepatic resection for colorectal metastasis are unclear.
METHODS: All patients undergoing hepatic resection for colorectal metastasis from 1991 to 2003 were identified, and the prognostic influence of margin width and other clinicopathologic factors were analyzed.
RESULTS: A total of 1019 patients with a clear description of margin width were included. Analysis of margin width as a continuous variable suggested the following grouping: group I, involved (n = 112, 11%); group II, <1-10 mm (n = 563, 55%); and group III, >10 mm (n = 344, 33.7%). On univariate analysis, there was a statistically significant difference in median survival between all 3 groups: group II versus group I (42 vs. 30 months, P < 0.01) and group III versus group II (55 vs. 42 months, P < 0.01). Margin width >1 cm retained statistical significance (P < 0.01) on multivariate analysis after adjusting for established risk factors. After adjustment, survival in group III was significantly better than either group I or II (P < 0.01), but there was no difference between groups I and II (P = 0.31).
CONCLUSIONS: This study provides evidence that margin width of >1 cm is optimal and is an independent predictor of survival after hepatic resection for colorectal metastasis. However, subcentimeter resections are also associated with favorable outcome and should not preclude patients from undergoing resection.

Entities:  

Mesh:

Year:  2007        PMID: 17667509      PMCID: PMC1933562          DOI: 10.1097/SLA.0b013e31811ea962

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  30 in total

1.  Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence.

Authors:  K S Hughes; R Simon; S Songhorabodi; M A Adson; D M Ilstrup; J G Fortner; B J Maclean; J H Foster; J M Daly; D Fitzherbert
Journal:  Surgery       Date:  1986-08       Impact factor: 3.982

2.  A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

Authors:  Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charles S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Steven R Alberts
Journal:  J Clin Oncol       Date:  2003-12-09       Impact factor: 44.544

3.  The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment.

Authors:  J S Wagner; M A Adson; J A Van Heerden; M H Adson; D M Ilstrup
Journal:  Ann Surg       Date:  1984-05       Impact factor: 12.969

4.  Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection.

Authors:  Norihiro Kokudo; Yoshio Miki; Sachiko Sugai; Akio Yanagisawa; Yo Kato; Yoshihiro Sakamoto; Junji Yamamoto; Toshiharu Yamaguchi; Tetsuichiro Muto; Masatoshi Makuuchi
Journal:  Arch Surg       Date:  2002-07

Review 5.  Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases.

Authors: 
Journal:  Surgery       Date:  1988-03       Impact factor: 3.982

6.  Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment.

Authors:  K Hughes; J Scheele; P H Sugarbaker
Journal:  Surg Clin North Am       Date:  1989-04       Impact factor: 2.741

7.  One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants.

Authors:  R Doci; L Gennari; P Bignami; F Montalto; A Morabito; F Bozzetti
Journal:  Br J Surg       Date:  1991-07       Impact factor: 6.939

8.  Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade.

Authors:  William R Jarnagin; Mithat Gonen; Yuman Fong; Ronald P DeMatteo; Leah Ben-Porat; Sarah Little; Carlos Corvera; Sharon Weber; Leslie H Blumgart
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

9.  Determinants of survival in liver resection for colorectal secondaries.

Authors:  H Ekberg; K G Tranberg; R Andersson; C Lundstedt; I Hägerstrand; J Ranstam; S Bengmark
Journal:  Br J Surg       Date:  1986-09       Impact factor: 6.939

10.  Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy.

Authors:  Alexander A Parikh; Bernhard Gentner; Tsung-Teh Wu; Steven A Curley; Lee M Ellis; Jean-Nicolas Vauthey
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.267

View more
  78 in total

1.  Clinical risk score can be used to select patients for staging laparoscopy and laparoscopic ultrasound for colorectal liver metastases.

Authors:  A J Shah; J Phull; M D Finch-Jones
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

Review 2.  Hepatic resection for colorectal metastases: the impact of surgical margin status on outcome.

Authors:  George A Poultsides; Richard D Schulick; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2010-02       Impact factor: 3.647

3.  Safety analysis of the oncological outcome after vein-preserving surgery for colorectal liver metastases detached from the main hepatic veins.

Authors:  Federico Tomassini; Italo Bonadio; Peter Smeets; Karen De Paepe; Giammauro Berardi; Liesbeth Ferdinande; Stéphanie Laurent; Louis J Libbrecht; Karen Geboes; Roberto I Troisi
Journal:  Langenbecks Arch Surg       Date:  2015-08-12       Impact factor: 3.445

4.  Minimally invasive liver surgery for metastases from colorectal cancer: oncologic outcome and prognostic factors.

Authors:  Baki Topal; Joyce Tiek; Steffen Fieuws; Raymond Aerts; Eric Van Cutsem; Tania Roskams; Hans Prenen
Journal:  Surg Endosc       Date:  2012-02-07       Impact factor: 4.584

5.  Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.

Authors:  Xiaodong Wang; Constantinos T Sofocleous; Joseph P Erinjeri; Elena N Petre; Mithat Gonen; Kinh G Do; Karen T Brown; Anne M Covey; Lynn A Brody; William Alago; Raymond H Thornton; Nancy E Kemeny; Stephen B Solomon
Journal:  Cardiovasc Intervent Radiol       Date:  2012-04-26       Impact factor: 2.740

6.  Recent progress in laparoscopic liver resection.

Authors:  Tadashi Tsukamoto; Akishige Kanazawa; Shintaro Kodai; Shoji Kubo
Journal:  Clin J Gastroenterol       Date:  2013-01-08

7.  Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy.

Authors:  Ilia Gur; Brian S Diggs; Jesse A Wagner; Gina M Vaccaro; Charles D Lopez; Brett C Sheppard; Susan L Orloff; Kevin G Billingsley
Journal:  J Gastrointest Surg       Date:  2013-10-04       Impact factor: 3.452

8.  Accomplishments in 2008 in the management of curable metastatic colorectal cancer.

Authors:  René Adam; Emir Hoti; Gunnar Folprecht; Al B Benson
Journal:  Gastrointest Cancer Res       Date:  2009-09

9.  Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy.

Authors:  Andreas Andreou; Thomas A Aloia; Antoine Brouquet; Paxton V Dickson; Giuseppe Zimmitti; Dipen M Maru; Scott Kopetz; Evelyne M Loyer; Steven A Curley; Eddie K Abdalla; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2013-06       Impact factor: 12.969

10.  Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis.

Authors:  Michihiro Hayashi; Yoshihiro Inoue; Koji Komeda; Tetsunosuke Shimizu; Mitsuhiro Asakuma; Fumitoshi Hirokawa; Yoshiharu Miyamoto; Junji Okuda; Atsushi Takeshita; Yuro Shibayama; Nobuhiko Tanigawa
Journal:  BMC Surg       Date:  2010-09-27       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.